Effects of Low-Dose Estrogen Replacement During Childhood on Pubertal Development and Gonadotropin Concentrations in Patients With Turner Syndrome: Results of a Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Open Access
- 1 September 2014
- journal article
- research article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 99 (9) , E1754-E1764
Abstract
Context: The optimal approach to estrogen replacement in girls with Turner syndrome has not been determined. Objective: The aim of the study was to assess the effects of an individualized regimen of low-dose ethinyl estradiol (EE2) during childhood from as early as age 5, followed by a pubertal induction regimen starting after age 12 and escalating to full replacement over 4 years. Design: This study was a prospective, randomized, double-blind, placebo-controlled clinical trial. Setting: The study was conducted at two US pediatric endocrine centers. Subjects: Girls with Turner syndrome (n = 149), aged 5.0–12.5 years, were enrolled; data from 123 girls were analyzable for pubertal onset. Intervention(s): Interventions comprised placebo or recombinant GH injections three times a week, with daily oral placebo or oral EE2 during childhood (25 ng/kg/d, ages 5–8 y; 50 ng/kg/d, ages >8–12 y); after age 12, all patients received escalating EE2 starting at a nominal dosage of 100 ng/kg/d. Placebo/EE2 dosages were reduced by 50% for breast development before age 12 years, vaginal bleeding before age 14 years, or undue advance in bone age. Main Outcome Measures: The main outcome measures for this report were median ages at Tanner breast stage ≥2, median age at menarche, and tempo of puberty (Tanner 2 to menarche). Patterns of gonadotropin secretion and impact of childhood EE2 on gonadotropins also were assessed. Results: Compared with recipients of oral placebo (n = 62), girls who received childhood low-dose EE2 (n = 61) had significantly earlier thelarche (median, 11.6 vs 12.6 y, P < 0.001) and slower tempo of puberty (median, 3.3 vs 2.2 y, P = 0.003); both groups had delayed menarche (median, 15.0 y). Among childhood placebo recipients, girls who had spontaneous breast development before estrogen exposure had significantly lower median FSH values than girls who did not. Conclusions: In addition to previously reported effects on cognitive measures and GH-mediated height gain, childhood estrogen replacement significantly normalized the onset and tempo of puberty. Childhood low-dose estrogen replacement should be considered for girls with Turner syndrome.Keywords
This publication has 68 references indexed in Scilit:
- The Development of Female Sexual Behavior Requires Prepubertal EstradiolJournal of Neuroscience, 2011
- Growth Hormone plus Childhood Low-Dose Estrogen in Turner's SyndromeNew England Journal of Medicine, 2011
- Estrogen and androgen receptors: regulators of fuel homeostasis and emerging targets for diabetes and obesityTrends in Endocrinology & Metabolism, 2011
- Turner SyndromeChild and Adolescent Psychiatric Clinics of North America, 2007
- Growth hormone therapy of Turner's syndrome: Beneficial effect on adult heightThe Journal of Pediatrics, 1998
- Lipid abnormalities in Turner syndromeThe Journal of Pediatrics, 1995
- Comparison of Transdermal and Oral Estrogen Therapy in Girls with Turner's SyndromeJournal of Pediatric Endocrinology and Metabolism, 1995
- The Psychological Significance of Secondary Sexual Characteristics in Nine- to Eleven-Year-Old GirlsChild Development, 1988
- Effect of low doses of estradiol on 6-month growth rates and predicted height in patients with Turner syndromeThe Journal of Pediatrics, 1986
- A Preliminary Study of the Effect of Estrogen Dose on Growth in Turner's SyndromeNew England Journal of Medicine, 1983